Novo plans to begin selling its FDA-approved weight-loss pill in the US in January following Oasis 4 trial results showing 13.6% average weight loss over 64 weeks, while Lilly's oral alternative, orforglipron, received expedited FDA review under a new 2025 voucher program and could be approved as soon as March, according to CEO Dave Ricks
It is administered weekly via injection and works by mimicking a natural hormone called GLP-1 (glucagon-like peptide-1), which helps regulate blood sugar levels
This removes surface starch that would otherwise make the cooked rice gummy and clumpy, resulting in distinct, fluffy grains that hold their structure beautifully in the bowl
She's now wearing pants she shelved 16 years ago, and seeing results she could never sustain on diets like Weight Watchers and Optavia
Take the First Step Towards a Healthier, Energized Life